Peripherex
Peripheral Vision Impairment Diagnosis and Monitoring Solution
StartupPeripherex is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2021. Peripheral Vision Impairment Diagnosis and Monitoring Solution. The company has raised a total of $3M across 1 funding round, currently at the A stage. Peripherex was founded by Jeffrey Goldberg and Yitzi Kempinski . Key investors include BIOLIGHT Life Sciences. The company has 1-10 employees. Core technologies: Platforms & Interfaces, Software.
With $3M in total funding, Peripherex is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2B2C/B2B business model. Product stage: Clinical Trial.
- StageA
- ProductClinical Trial
- ModelB2B2C, B2B
- Employees1-10
- HQTel Aviv-Yafo
- Last Round$3M
- BIOLIGHT Life SciencesLead
Jeffrey GoldbergCo-founder
Yitzi Kempinski Co-founder & CTO
What does Peripherex do?
Peripherex has developed a software solution designed to diagnose and monitor peripheral vision impairment, both at home and in the office. The company’s product employs sophisticated eye-tracking software and can run on any personal computer or tablet with a built-in camera, eliminating the need for additional hardware and providing eye care professionals with the tools to diagnose and monitor glaucoma and other diseases.
How much funding has Peripherex raised?
Peripherex has raised $3M in total funding across 1 rounds. The company is currently at the A stage. Key investors include BIOLIGHT Life Sciences.
Who founded Peripherex?
Peripherex was founded in 2021 by Jeffrey Goldberg (Co-founder), Yitzi Kempinski (Co-founder & CTO).
What sector is Peripherex in?
Peripherex operates in Health Tech & Life Sciences, Digital Healthcare, Patient Remote Monitoring, Digital Medical Diagnostics, with core technologies in Platforms & Interfaces, Software. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Providers.
Where is Peripherex located?
Peripherex is based in Tel Aviv-Yafo, Israel.